Global Drug Delivery CDMO Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030
1 Market Overview
- 1.1 Product Overview and Scope of Drug Delivery CDMO Services
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Drug Delivery CDMO Services by Type
- 1.3.1 Overview: Global Drug Delivery CDMO Services Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global Drug Delivery CDMO Services Consumption Value Market Share by Type in 2023
- 1.3.3 In Vivo Delivery
- 1.3.4 In Vitro Delivery
- 1.4 Global Drug Delivery CDMO Services Market by Application
- 1.4.1 Overview: Global Drug Delivery CDMO Services Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Macromolecule Drugs
- 1.4.3 Small Molecule Drug
- 1.4.4 Others
- 1.5 Global Drug Delivery CDMO Services Market Size & Forecast
- 1.6 Global Drug Delivery CDMO Services Market Size and Forecast by Region
- 1.6.1 Global Drug Delivery CDMO Services Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global Drug Delivery CDMO Services Market Size by Region, (2019-2030)
- 1.6.3 North America Drug Delivery CDMO Services Market Size and Prospect (2019-2030)
- 1.6.4 Europe Drug Delivery CDMO Services Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific Drug Delivery CDMO Services Market Size and Prospect (2019-2030)
- 1.6.6 South America Drug Delivery CDMO Services Market Size and Prospect (2019-2030)
- 1.6.7 Middle East and Africa Drug Delivery CDMO Services Market Size and Prospect (2019-2030)
2 Company Profiles
- 2.1 Evonik Health Care
- 2.1.1 Evonik Health Care Details
- 2.1.2 Evonik Health Care Major Business
- 2.1.3 Evonik Health Care Drug Delivery CDMO Services Product and Solutions
- 2.1.4 Evonik Health Care Drug Delivery CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Evonik Health Care Recent Developments and Future Plans
- 2.2 Sanner
- 2.2.1 Sanner Details
- 2.2.2 Sanner Major Business
- 2.2.3 Sanner Drug Delivery CDMO Services Product and Solutions
- 2.2.4 Sanner Drug Delivery CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Sanner Recent Developments and Future Plans
- 2.3 Lubrizol Life Science Health (LLS Health)
- 2.3.1 Lubrizol Life Science Health (LLS Health) Details
- 2.3.2 Lubrizol Life Science Health (LLS Health) Major Business
- 2.3.3 Lubrizol Life Science Health (LLS Health) Drug Delivery CDMO Services Product and Solutions
- 2.3.4 Lubrizol Life Science Health (LLS Health) Drug Delivery CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Lubrizol Life Science Health (LLS Health) Recent Developments and Future Plans
- 2.4 Kindeva Drug Delivery
- 2.4.1 Kindeva Drug Delivery Details
- 2.4.2 Kindeva Drug Delivery Major Business
- 2.4.3 Kindeva Drug Delivery Drug Delivery CDMO Services Product and Solutions
- 2.4.4 Kindeva Drug Delivery Drug Delivery CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Kindeva Drug Delivery Recent Developments and Future Plans
- 2.5 Beijing TheraXyte Biotechnology
- 2.5.1 Beijing TheraXyte Biotechnology Details
- 2.5.2 Beijing TheraXyte Biotechnology Major Business
- 2.5.3 Beijing TheraXyte Biotechnology Drug Delivery CDMO Services Product and Solutions
- 2.5.4 Beijing TheraXyte Biotechnology Drug Delivery CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Beijing TheraXyte Biotechnology Recent Developments and Future Plans
- 2.6 Altasciences
- 2.6.1 Altasciences Details
- 2.6.2 Altasciences Major Business
- 2.6.3 Altasciences Drug Delivery CDMO Services Product and Solutions
- 2.6.4 Altasciences Drug Delivery CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 Altasciences Recent Developments and Future Plans
- 2.7 Stevanato Group
- 2.7.1 Stevanato Group Details
- 2.7.2 Stevanato Group Major Business
- 2.7.3 Stevanato Group Drug Delivery CDMO Services Product and Solutions
- 2.7.4 Stevanato Group Drug Delivery CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 Stevanato Group Recent Developments and Future Plans
- 2.8 RiboBio
- 2.8.1 RiboBio Details
- 2.8.2 RiboBio Major Business
- 2.8.3 RiboBio Drug Delivery CDMO Services Product and Solutions
- 2.8.4 RiboBio Drug Delivery CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
- 2.8.5 RiboBio Recent Developments and Future Plans
- 2.9 Lonza
- 2.9.1 Lonza Details
- 2.9.2 Lonza Major Business
- 2.9.3 Lonza Drug Delivery CDMO Services Product and Solutions
- 2.9.4 Lonza Drug Delivery CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
- 2.9.5 Lonza Recent Developments and Future Plans
- 2.10 Thermo Fisher Scientific
- 2.10.1 Thermo Fisher Scientific Details
- 2.10.2 Thermo Fisher Scientific Major Business
- 2.10.3 Thermo Fisher Scientific Drug Delivery CDMO Services Product and Solutions
- 2.10.4 Thermo Fisher Scientific Drug Delivery CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
- 2.10.5 Thermo Fisher Scientific Recent Developments and Future Plans
- 2.11 Catalent
- 2.11.1 Catalent Details
- 2.11.2 Catalent Major Business
- 2.11.3 Catalent Drug Delivery CDMO Services Product and Solutions
- 2.11.4 Catalent Drug Delivery CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
- 2.11.5 Catalent Recent Developments and Future Plans
- 2.12 Asymchem
- 2.12.1 Asymchem Details
- 2.12.2 Asymchem Major Business
- 2.12.3 Asymchem Drug Delivery CDMO Services Product and Solutions
- 2.12.4 Asymchem Drug Delivery CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
- 2.12.5 Asymchem Recent Developments and Future Plans
- 2.13 Samsung Biologics
- 2.13.1 Samsung Biologics Details
- 2.13.2 Samsung Biologics Major Business
- 2.13.3 Samsung Biologics Drug Delivery CDMO Services Product and Solutions
- 2.13.4 Samsung Biologics Drug Delivery CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
- 2.13.5 Samsung Biologics Recent Developments and Future Plans
- 2.14 CD Bioarticles
- 2.14.1 CD Bioarticles Details
- 2.14.2 CD Bioarticles Major Business
- 2.14.3 CD Bioarticles Drug Delivery CDMO Services Product and Solutions
- 2.14.4 CD Bioarticles Drug Delivery CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
- 2.14.5 CD Bioarticles Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Drug Delivery CDMO Services Revenue and Share by Players (2019-2024)
- 3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of Drug Delivery CDMO Services by Company Revenue
- 3.2.2 Top 3 Drug Delivery CDMO Services Players Market Share in 2023
- 3.2.3 Top 6 Drug Delivery CDMO Services Players Market Share in 2023
- 3.3 Drug Delivery CDMO Services Market: Overall Company Footprint Analysis
- 3.3.1 Drug Delivery CDMO Services Market: Region Footprint
- 3.3.2 Drug Delivery CDMO Services Market: Company Product Type Footprint
- 3.3.3 Drug Delivery CDMO Services Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Drug Delivery CDMO Services Consumption Value and Market Share by Type (2019-2024)
- 4.2 Global Drug Delivery CDMO Services Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
- 5.1 Global Drug Delivery CDMO Services Consumption Value Market Share by Application (2019-2024)
- 5.2 Global Drug Delivery CDMO Services Market Forecast by Application (2025-2030)
6 North America
- 6.1 North America Drug Delivery CDMO Services Consumption Value by Type (2019-2030)
- 6.2 North America Drug Delivery CDMO Services Consumption Value by Application (2019-2030)
- 6.3 North America Drug Delivery CDMO Services Market Size by Country
- 6.3.1 North America Drug Delivery CDMO Services Consumption Value by Country (2019-2030)
- 6.3.2 United States Drug Delivery CDMO Services Market Size and Forecast (2019-2030)
- 6.3.3 Canada Drug Delivery CDMO Services Market Size and Forecast (2019-2030)
- 6.3.4 Mexico Drug Delivery CDMO Services Market Size and Forecast (2019-2030)
7 Europe
- 7.1 Europe Drug Delivery CDMO Services Consumption Value by Type (2019-2030)
- 7.2 Europe Drug Delivery CDMO Services Consumption Value by Application (2019-2030)
- 7.3 Europe Drug Delivery CDMO Services Market Size by Country
- 7.3.1 Europe Drug Delivery CDMO Services Consumption Value by Country (2019-2030)
- 7.3.2 Germany Drug Delivery CDMO Services Market Size and Forecast (2019-2030)
- 7.3.3 France Drug Delivery CDMO Services Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom Drug Delivery CDMO Services Market Size and Forecast (2019-2030)
- 7.3.5 Russia Drug Delivery CDMO Services Market Size and Forecast (2019-2030)
- 7.3.6 Italy Drug Delivery CDMO Services Market Size and Forecast (2019-2030)
8 Asia-Pacific
- 8.1 Asia-Pacific Drug Delivery CDMO Services Consumption Value by Type (2019-2030)
- 8.2 Asia-Pacific Drug Delivery CDMO Services Consumption Value by Application (2019-2030)
- 8.3 Asia-Pacific Drug Delivery CDMO Services Market Size by Region
- 8.3.1 Asia-Pacific Drug Delivery CDMO Services Consumption Value by Region (2019-2030)
- 8.3.2 China Drug Delivery CDMO Services Market Size and Forecast (2019-2030)
- 8.3.3 Japan Drug Delivery CDMO Services Market Size and Forecast (2019-2030)
- 8.3.4 South Korea Drug Delivery CDMO Services Market Size and Forecast (2019-2030)
- 8.3.5 India Drug Delivery CDMO Services Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia Drug Delivery CDMO Services Market Size and Forecast (2019-2030)
- 8.3.7 Australia Drug Delivery CDMO Services Market Size and Forecast (2019-2030)
9 South America
- 9.1 South America Drug Delivery CDMO Services Consumption Value by Type (2019-2030)
- 9.2 South America Drug Delivery CDMO Services Consumption Value by Application (2019-2030)
- 9.3 South America Drug Delivery CDMO Services Market Size by Country
- 9.3.1 South America Drug Delivery CDMO Services Consumption Value by Country (2019-2030)
- 9.3.2 Brazil Drug Delivery CDMO Services Market Size and Forecast (2019-2030)
- 9.3.3 Argentina Drug Delivery CDMO Services Market Size and Forecast (2019-2030)
10 Middle East & Africa
- 10.1 Middle East & Africa Drug Delivery CDMO Services Consumption Value by Type (2019-2030)
- 10.2 Middle East & Africa Drug Delivery CDMO Services Consumption Value by Application (2019-2030)
- 10.3 Middle East & Africa Drug Delivery CDMO Services Market Size by Country
- 10.3.1 Middle East & Africa Drug Delivery CDMO Services Consumption Value by Country (2019-2030)
- 10.3.2 Turkey Drug Delivery CDMO Services Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia Drug Delivery CDMO Services Market Size and Forecast (2019-2030)
- 10.3.4 UAE Drug Delivery CDMO Services Market Size and Forecast (2019-2030)
11 Market Dynamics
- 11.1 Drug Delivery CDMO Services Market Drivers
- 11.2 Drug Delivery CDMO Services Market Restraints
- 11.3 Drug Delivery CDMO Services Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Drug Delivery CDMO Services Industry Chain
- 12.2 Drug Delivery CDMO Services Upstream Analysis
- 12.3 Drug Delivery CDMO Services Midstream Analysis
- 12.4 Drug Delivery CDMO Services Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Drug Delivery CDMO Services market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Drug delivery CDMO services often refer to contract development and manufacturing organizations (CDMOs) in drug development and production. These service providers focus on providing a range of services to pharmaceutical companies, including R&D and manufacturing services in drug delivery. Drug delivery refers to guiding drugs into the patient's body through different routes to improve the therapeutic effect or improve the patient's medication experience.
The Global Info Research report includes an overview of the development of the Drug Delivery CDMO Services industry chain, the market status of Macromolecule Drugs (In Vivo Delivery, In Vitro Delivery), Small Molecule Drug (In Vivo Delivery, In Vitro Delivery), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Drug Delivery CDMO Services.
Regionally, the report analyzes the Drug Delivery CDMO Services markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Drug Delivery CDMO Services market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Drug Delivery CDMO Services market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Drug Delivery CDMO Services industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., In Vivo Delivery, In Vitro Delivery).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Drug Delivery CDMO Services market.
Regional Analysis: The report involves examining the Drug Delivery CDMO Services market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Drug Delivery CDMO Services market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Drug Delivery CDMO Services:
Company Analysis: Report covers individual Drug Delivery CDMO Services players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Drug Delivery CDMO Services This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Macromolecule Drugs, Small Molecule Drug).
Technology Analysis: Report covers specific technologies relevant to Drug Delivery CDMO Services. It assesses the current state, advancements, and potential future developments in Drug Delivery CDMO Services areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Drug Delivery CDMO Services market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Drug Delivery CDMO Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
In Vivo Delivery
In Vitro Delivery
Market segment by Application
Macromolecule Drugs
Small Molecule Drug
Others
Market segment by players, this report covers
Evonik Health Care
Sanner
Lubrizol Life Science Health (LLS Health)
Kindeva Drug Delivery
Beijing TheraXyte Biotechnology
Altasciences
Stevanato Group
RiboBio
Lonza
Thermo Fisher Scientific
Catalent
Asymchem
Samsung Biologics
CD Bioarticles
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Drug Delivery CDMO Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Drug Delivery CDMO Services, with revenue, gross margin and global market share of Drug Delivery CDMO Services from 2019 to 2024.
Chapter 3, the Drug Delivery CDMO Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Drug Delivery CDMO Services market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drug Delivery CDMO Services.
Chapter 13, to describe Drug Delivery CDMO Services research findings and conclusion.